These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16137731

  • 1. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G, Slack R, Carbott D, Khan S, Steadman L, Dickson RB.
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [Abstract] [Full Text] [Related]

  • 2. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 3. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 02; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 4. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 Jun 02; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 5. Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
    Cheung RS, Brooling JT, Johnson MM, Riehle KJ, Campbell JS, Fausto N.
    Carcinogenesis; 2007 Dec 02; 28(12):2624-31. PubMed ID: 17698969
    [Abstract] [Full Text] [Related]

  • 6. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 7. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 28; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 8. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.
    Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691
    [Abstract] [Full Text] [Related]

  • 9. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium.
    Smith GH, Mehrel T, Roop DR.
    Cell Growth Differ; 1990 Apr 01; 1(4):161-70. PubMed ID: 1707299
    [Abstract] [Full Text] [Related]

  • 10. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL, Kendrick H, Magnay FA, Vafaizadeh V, Groner B, Smalley MJ.
    Oncogene; 2012 Feb 16; 31(7):869-83. PubMed ID: 21765473
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ.
    Cancer Res; 1997 Feb 15; 57(4):600-3. PubMed ID: 9044833
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor alpha and mouse models of human breast cancer.
    Humphreys RC, Hennighausen L.
    Oncogene; 2000 Feb 21; 19(8):1085-91. PubMed ID: 10713694
    [Abstract] [Full Text] [Related]

  • 13. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE.
    Cancer Res; 2008 Oct 01; 68(19):7711-7. PubMed ID: 18829523
    [Abstract] [Full Text] [Related]

  • 14. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D, Kittrell FS, Oborn CJ, Schwartz M.
    Cancer Res; 1993 Feb 01; 53(3):668-74. PubMed ID: 8425201
    [Abstract] [Full Text] [Related]

  • 15. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 16. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 17. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
    Gardner HP, Ha SI, Reynolds C, Chodosh LA.
    Cancer Res; 2000 Oct 01; 60(19):5571-7. PubMed ID: 11034105
    [Abstract] [Full Text] [Related]

  • 18. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW, Leder P.
    Oncogene; 1994 Dec 01; 9(12):3417-26. PubMed ID: 7970700
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R, Herzer U, Schenkel J, Weiher H.
    Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445
    [Abstract] [Full Text] [Related]

  • 20. Reducing mammary cancer risk through premature stem cell senescence.
    Boulanger CA, Smith GH.
    Oncogene; 2001 Apr 26; 20(18):2264-72. PubMed ID: 11402321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.